Form D · Pharmaceuticals
Ala Wai Pharma, Inc.
Honolulu, HI · CIK 0001583673
Offering snapshot reported Aug 6, 2013 · SEC filing
- Reported sold
- $300K Offering amount: $300K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 28, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 6, 2013 | Initial | $300,000 | No comparison | 3 | SEC filing |
| Aug 6, 2013 | Initial | $500,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-200790
Source: Form D, filed Aug 6, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Omar Sultan | Executive |
| Arthur Ushijima | Director |
| Barry M. Weinman | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2444 Dole Street, Bachman 105
Honolulu, HI, 96822
Honolulu, HI, 96822